Promore Pharma AB (publ) Interim report January – June 2019

2019-08-28

April to June

  • Net sales amounted to 0.7 (0) MSEK.
  • The operating loss for the period was 7.4 (-10.8) MSEK
  • Net loss was 7.3 (- 9.8) MSEK, corresponding to earnings per share of SEK -0.36 (-0.48)
  • Cash flow from operating activities amounted to -6.9 (-8.6) MSEK
  • Cash and cash equivalents amounted to 19.7 (46.0) MSEK

Läs hela meddelandet på Promore Pharmas hemsida.

Läs mer..



Västra Hamnen Corporate Finance AB | Jungmansgatan 12 | 211 11 Malmö | 040-200 250 | info@vhcorp.se